Lennox-gastaut Syndrome

• FDA label_change · 2024-05-15
  FDA Approved: CLOBAZAM — Supplemental Application (Aurobindo Pharma Limited)

  FDA approved a supplemental application for CLOBAZAM (clobazam) from Aurobindo Pharma Limited, updating the existing product through a suppl…

• FDA label_change · 2020-12-09
  FDA Approved: SYMPAZAN — Supplemental Application (Aquestive Therapeutics)

  FDA approved a supplemental application for Sympazan (clobazam) from Aquestive Therapeutics, resulting in changes to the drug’s labeling/ind…

• FDA label_change · 2016-06-16
  FDA Approved: ONFI — Supplemental Application (Lundbeck Pharmaceuticals LLC)

  FDA approved a supplemental application for ONFI (clobazam) submitted by Lundbeck Pharmaceuticals LLC.

• FDA label_change · 2012-08-31
  FDA Approved: FELBAMATE — Supplemental Application (Mylan Pharmaceuticals Inc.)

  FDA approved a supplemental application for felbamate submitted by Mylan Pharmaceuticals Inc.